Skip to main content
All lobbying filings

SPARK THERAPEUTICS, INC.

Lobbying for SPARK THERAPEUTICS, INC.

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$190,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Pennsylvania

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

H.R. 2666/S. 4204 - MVP Act, all provisions. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025, provisions related to health.

Health Issues

H.R. 1509/S. 752 - Accelerating Kids Access to Care Act of 2025, all provisions. H.R. 1262/S. 932 - Give Kids a Chance Act of 2025, all provisions.

 Bills named in this filing 7
  • H.R. 2666
    Medicaid VBPs for Patients Act
  • S. 4204
    Rural Health Innovation Act of 2026
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
  • S. 752
    Accelerating Kids’ Access to Care Act
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
  • S. 932
    Give Kids a Chance Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem